Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference22 articles.
1. Pathogenesis of NIDDM. A balanced overview;DeFronzo;Diabetes Care,1999
2. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM?;Taylor;Diabetes,1994
3. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies;Meece;Curr. Med. Res. Opin.,2007
4. Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs. glibenclamide monotherapy in Japanese patients with type 2 diabetes;Seino;Curr. Med. Res. Opin.,2010
5. Incretin-based therapies: viewpoints on the way to consensus;Nauck;Diabetes Care,2009
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23
2. Activation and signaling mechanism revealed by GPR119-Gs complex structures;Nature Communications;2022-11-17
3. GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats;Pharmaceuticals;2022-01-05
4. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16
5. GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus;Bioorganic Chemistry;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3